close

Enter

Log in using OpenID

Bone Cancer Treatment Market Accrues Phenomenally by 2026 with a Staggering CAGR

embed
Cancer is one of the most prevalent fatal chronic disorders with a high mortality rate due to its extremely invasive nature and prolonged duration of disease. Bone cancer is a type of cancer in which the bone tissues grows in an uncontrollable manne
Bone Cancer Treatment Market Accrues
Phenomenally by 2026 with a Staggering CAGR
Bone Cancer Treatment Market - Global Industry Insights, Trends, Outlook, and
Opportunity Analysis, 2018-2026
Cancer is one of the most prevalent fatal chronic disorders with a high mortality rate due to its
extremely invasive nature and prolonged duration of disease. Bone cancer is a type of cancer in which
the bone tissues grows in an uncontrollable manner. This growth may be benign or malignant. In most
cases bone cancer results from other cancers such as lung cancer, kidney cancer, prostate cancer, and
breast cancer, which is also called secondary or metastatic bone cancer.
Get The PDF Brochure of This Report @
https://www.coherentmarketinsights.com/insight/request-sample/93
The major and primary symptom of bone cancer is severe bone pain, which usually intensifies with
time. In addition to pain, symptoms such as weight loss, fever, fatigue, muscle pain, bone crack,
osteoporosis and osteopenia are also identified. Diagnosis of bone cancer includes understanding
patient’s history and reasons causing pain. Besides, bone cancer can be diagnosed using imaging
techniques such as computerized tomography (CT), bone scan, magnetic resonance imaging (MRI),
positron emission tomography (PET) scanning, and biopsy tests.
Bone cancer treatment market can be classified on basis of type and treatment available for bone
cancer
The bone cancer treatment market is analyzed on the basis of type of bone cancer into primary bone
cancer and secondary bone cancer. Primary bone cancer originates from fast and uncontrollable growth
of the bone and other related tissues. Types of primary bone cancer include osteosarcoma,
chondrosarcoma, Ewing’s sarcoma, spindle cell sarcoma, and chordoma. Secondary bone cancer, also
called metastatic bone cancer, arises due to spreading of cancer cells from different parts of body. It is
also referred as metastatic bone cancer.
Global players involved in the bone cancer treatment market
Major players involved in bone cancer treatment market include Amgen Inc., Actavis plc, Novartis
International AG, Debiopharm Group, Pfizer, Inc., and Eli Lilly and Company.
Dr. Andre Roodt, a researcher at the University of Free State has developed pain relieving drug for
bone cancer patients in December 2016. The drug is a liquid radioactive isotope that can detect cancer
in the body. Innovation in treatment options would lead to better therapeutic outcomes.
On the basis of therapies or treatments available, the global bone cancer treatment market is classified
as radiation therapy, chemotherapy, cryosurgery, and surgical treatments. The major surgical practices
used to treat bone cancer are limb amputation surgery and limb salvage surgery or limb sparing surgery.
In radiation therapy, high energy X-rays or gamma-rays are used to destroy tumors. Chemotherapy is a
pharmacological treatment that involves the use of anti-cancer drugs. Major drugs include strontium-89
chloride, bisphosphonates, methotrexate, and doxorubicin, among others. Cryosurgery is sometimes
used in lieu of conventional surgery to kill tumors.
Increasing disease incidence creating favorable growth environment for Bone cancer treatment
market
Developed markets such as the U.S., U.K., Japan, Canada, Australia, Germany, and Spain have a robust
healthcare infrastructure that provides patients with easy access to advanced healthcare facilities, which
aids in early diagnosis of bone cancer. According to the American Cancer Society (ACS),
approximately 3,300 new cases of bone cancer are expected to be diagnosed in 2016, resulting in
around 1,490 deaths in the same year. Moreover, the ACS sates that in adults over 40% of primary bone
cancers are chondrosarcomas. This is followed by osteosarcomas (28%), chordomas (10%), Ewing
tumors (8%), and malignant fibrous histiocytoma/fibrosarcomas (4%). According to 2016 Cancer.Net
estimates, 3,300 people of all ages in the U.S. would be diagnosed with primary bone cancer. New
cases of bone cancer being diagnosed would propel growth of the bone cancer treatment market in the
U.S. On the other hand, rising incidence rate in Asia Pacific is expected to be a major growth factor for
the global Bone Cancer Treatment Market, supported by growing awareness among the populace.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: [email protected]
Author
ravikiran
ravikiran298   documents Email
Document
Category
Health and Medicine
Views
2
File Size
360 KB
Tags
treatment
1/--pages
Report inappropriate content